Supernus Pharmaceuticals ... (SUPN)
NASDAQ: SUPN
· Real-Time Price · USD
42.34
0.17 (0.40%)
At close: Aug 15, 2025, 10:01 AM
Supernus Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 165.45M | 149.82M | 174.16M | 175.69M | 168.32M | 143.64M | 164.31M | 153.88M | 135.56M | 153.76M | 167.33M | 177.35M | 170.05M | 152.51M | 159.05M | 148.46M | 141.33M | 130.93M |
Cost of Revenue | 38.15M | 15.76M | 26.1M | 17.58M | 38.62M | 37.06M | 41.3M | 19.6M | 21.09M | 23.46M | 22.95M | 25.88M | 20.46M | 17.93M | 16.99M | 18.09M | 25.03M | 14.95M |
Gross Profit | 127.31M | 134.06M | 148.06M | 138.02M | 129.7M | 106.59M | 123.01M | 134.28M | 114.47M | 130.3M | 144.37M | 151.47M | 149.59M | 134.57M | 142.06M | 130.38M | 116.3M | 115.98M |
Operating Income | 11.14M | -10.26M | 21.41M | 40.84M | 18.21M | -4.25M | 18.99M | 8.14M | -17.59M | 8.88M | 34.33M | 1.77M | 11.35M | 17.33M | 6.1M | 32.6M | 34.11M | 13.21M |
Interest Income | 4.53M | 4.42M | 4.98M | 4.1M | 3.73M | 3.4M | 1.99M | 1.75M | 1.37M | 5.35M | 2.4M | 2.8M | 1.79M | 14.7M | 1.89M | 2.28M | 2.59M | 3.81M |
Pretax Income | 16.67M | -5.83M | 26.38M | 44.94M | 26.3M | 243K | 990K | 9.89M | -17.13M | 9.02M | 35.14M | -444K | 11.32M | 14.72M | 2.05M | 28.96M | 31.23M | 10.93M |
Net Income | 22.5M | -11.83M | 15.33M | 38.5M | 19.92M | 124K | 1.18M | -15.98M | -831K | 16.95M | 25.48M | 1.75M | 7.87M | 25.62M | 2.44M | 21.56M | 23.73M | 5.69M |
Selling & General & Admin | 94.55M | 89.94M | 79.41M | 69.75M | 85.9M | 86.52M | 81.28M | 82.7M | 86.78M | 85.6M | 73.97M | 112.31M | 100.48M | 90.46M | 101.73M | 72.03M | 69.53M | 61.46M |
Research & Development | 21.61M | 26.93M | 28.05M | 29.04M | 25.58M | 24.32M | 22.74M | 22.66M | 24.38M | 21.21M | 17.77M | 19.55M | 16.39M | 20.84M | 21.08M | 19.65M | 15.46M | 34.28M |
Other Expenses | n/a | 27.45M | 18.6M | n/a | n/a | n/a | n/a | n/a | n/a | 19.97M | 20.7M | 20.64M | n/a | 20.64M | 12.03M | 6.01M | 5.95M | 6.01M |
Operating Expenses | 116.17M | 144.32M | 126.66M | 98.19M | 111.49M | 110.83M | 104.02M | 126.6M | 131.27M | 126.78M | 112.44M | 152.51M | 137.5M | 131.94M | 134.84M | 97.69M | 90.94M | 101.74M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 910K | 1.5M | 1.59M | 1.72M | 1.81M | 1.94M | 5.93M | 5.92M | 5.47M | 6.1M |
Selling & Marketing Expenses | n/a | 26.1M | 21M | 19.6M | 58.8M | 59.57M | 55.28M | 56.78M | 59.89M | 57.23M | 47.99M | 85.7M | 73.58M | 60.51M | 62.18M | 50.7M | 48.38M | 38.45M |
Cost & Expenses | 154.31M | 160.08M | 152.75M | 134.84M | 150.11M | 147.89M | 145.32M | 146.2M | 152.36M | 150.24M | 135.4M | 178.39M | 157.96M | 149.87M | 151.83M | 115.78M | 115.97M | 116.7M |
Income Tax Expense | -5.83M | 6M | 11.05M | 6.45M | 6.39M | 119K | -185K | 25.86M | -16.3M | -7.93M | 9.66M | -2.19M | 3.46M | -10.89M | -391K | 7.4M | 7.51M | 5.24M |
Shares Outstanding (Basic) | 56.02M | 55.87M | 55.47M | 55.15M | 54.98M | 54.8M | 54.65M | 54.61M | 54.5M | 54.38M | 54.1M | 53.79M | 53.43M | 59.35M | 53.24M | 53.19M | 53.01M | 52.93M |
Shares Outstanding (Diluted) | 56.64M | 55.87M | 56.47M | 56.02M | 55.72M | 55.63M | 55.3M | 54.61M | 54.5M | 62.45M | 62.09M | 55.03M | 61.4M | 61.41M | 54.53M | 54.33M | 54.72M | 54.2M |
EPS (Basic) | 0.40 | -0.21 | 0.28 | 0.70 | 0.36 | 0.00 | 0.02 | -0.29 | -0.02 | 0.31 | 0.47 | 0.03 | 0.15 | 0.43 | 0.05 | 0.41 | 0.45 | 0.11 |
EPS (Diluted) | 0.40 | -0.21 | 0.27 | 0.69 | 0.36 | 0.00 | 0.02 | -0.29 | -0.02 | 0.29 | 0.41 | 0.03 | 0.14 | 0.42 | 0.04 | 0.40 | 0.43 | 0.11 |
EBITDA | 37.99M | 17.79M | 45.23M | 65.03M | 38.92M | 16.5M | 40.66M | 29.54M | 4.49M | 24.13M | 58.13M | 23.05M | 33.65M | 23.99M | 20.71M | 41.49M | 43.35M | 23.63M |
EBIT | 16.67M | -2.6M | 26.38M | 44.94M | 26.3M | 243K | 18.99M | 7.68M | -16.22M | 3.53M | 36.73M | 1.28M | 12.09M | 2.63M | 7.99M | 34.88M | 36.7M | 17.03M |
Depreciation & Amortization | 21.32M | 20.38M | 18.84M | 20.1M | 20.71M | 20.75M | 21.68M | 21.86M | 20.71M | 20.6M | 21.4M | 21.77M | 21.56M | 21.36M | 12.72M | 6.61M | 6.65M | 6.61M |